2025

United Graduate School ofDrug Discovery and Medical Information Sciences
Gifu University

Doctorate Course(Three-year Post-M.S. Ph.D. Program)

Application Guidelines

Offered by:

Gifu University
andGifu Pharmaceutical University

United Graduate School of Drug Discovery and Medical Information Sciences
Gifu University
1-1 Yanagido, Gifu-shi, Gifu Prefecture 501-1194
Phone: +81-58-230-7602

Contents
I. Application Guidelines for the United Graduate School of Drug Discovery and Medical
Information Sciences, Gifu University
1. Admission Policy ....................................................................................................... 2
2. Diploma Policy..…………………………..…………………………………………2
3. Number of Admission Offers .................................................................................... 3
4. Admission Period & Application Eligibility ............................................................. 3
5. Approval of Application Eligibility ........................................................................... 5
6. Prior Consultation for Disabled Applicants............................................................... 7
7. Application Procedure ............................................................................................... 7
8. Examinations ........................................................................................................... 10
9. Date and Venue for Examination ............................................................................. 11
10. Announcement of Admission Decisions................................................................ 11
11. Registration ............................................................................................................ 12
12. About the clarification of the scope of control for “deemed exports”
under the Foreign Exchange and Foreign Trade Act (“FEFTA”) …………………..12
13. Notes to All Applicants.......................................................................................... 12
II. Overview of the United Graduate School of Drug Discovery and Medical Information Sciences(UGS-DDMIS)
1. Educational and Research Mission.......................................................................... 14
2. Doctorate Programs and Research Areas(1) Medicinal Sciences Program
1) Program Overview ........................................................................................... 142) Research Areas ................................................................................................. 14(2) Medical Information Sciences Program
1) Program Overview ........................................................................................... 152) Research Areas ................................................................................................. 15
3. Degrees Offered....................................................................................................... 16
4. Degree Requirements, Course Registration and Register Extending System ......... 16
5. Courses & Credits ................................................................................................... 18
III. Faculty List ............................................................................................................... 19
Ⅳ.Web Application Flow…………………………………………………………attachment

1I. Application Guidelines for the United Graduate School of Drug Discovery and Medical
Information Sciences, Gifu University
1.

Admission Policy

Educational principles and objectives
The United Graduate School of Drug Discovery and Medical Information Sciences pursues a coordinated andintegrated approach to education and research across different academic disciplines such as pharmaceutical science,
medical science, and engineering while treating the subjects of drug discovery and medical information as core
themes and the advanced life sciences as its academic foundation. Through such initiatives, it seeks to foster thedevelopment of advanced specialists who will be capable of pursuing careers in state-of-the-art domains as they
shape the next generation of progress in healthcare, medicine, and the life sciences through advanced specialization,
vision, and flexible thinking.

Desirable characteristics
Successful applicants will exhibit:

A high level of desire to master advanced, specialized knowledge relating to drug discovery
and to conduct research in the field
A strong resolution to pioneer practical research domains that are necessary in order todevelop individualized medicine
An appetite for locating one’s own research in the context of an international perspective andcommunicating one’s research findings to the world
A strong appetite for mastering the advanced, specialized knowledge and pursuing researchnecessary in order to provide safe and reliable medical care
A resolution to actively put one’s research findings to practical use in response to society’s
needs
General policy on the selection of program applicants
Admissions decisions will be made in a comprehensive manner based on the applicant's letter of intent, academic
record, master's thesis abstract, documentation of research achievements, and interview or oral examination inorder to assess the applicant's enthusiasm to acquire expert knowledge and promote research as well as theirdetermination to cultivate new and practical areas of research.

2.

Diploma Policy
Gifu University and Gifu Pharmaceutical University have come together to form the United Graduate Schoolof Drug Discovery and Medical Information Sciences to pursue programs of education and research in the2

areas of drug discovery and medical information. The programs, which offer doctoral degrees inpharmaceutical science, medical science, and engineering subject to rigorous credit certification and thesis
defense requirements, are dedicated to fostering the development of advanced specialists with the following
specialized skills:

1) Advanced specialized knowledge in fields related to drug discovery and medical information, and the ability
to put that knowledge to use
2) The ability to identify research topics in the fields of drug discovery and medical information and to analyze,
verify, and apply associated findings
3) The ability to present and debate research topics at scientific society meetings and other gatherings and tocomplete their exposition in international scientific papers
4) The ability to exercise leadership and cooperation through appropriate communication
5) The ability to conduct oneself and pursue research based on a proper sense of bioethics and research ethics

3.

Number of Admission Offers
2025
ProgramNo. of Offers

Medicinal Sciences

A few

Medical Information Sciences

A few

Total

A few

Note:
1) These numbers include both employed and international applicants.
2) Employed applicants are those who are working at the time of application and will continue to doso after enrollment in the program.
3) International applicants are those who do not have Japanese citizenship and will study at the
program on a student visa.

4.

Admission Period & Application Eligibility
Admission Period
The Second Admission: April or October 2025

3

Application Eligibility

Applicants to the UGS-DDMIS program must satisfy one of the following educational criteria asof now or by the following date.
Admission in April 2025: By the end of March 2025
October 2025: By the end of September 2025
i. Hold a master’s degree or professional degree from a Japanese school;
ii. Hold a master’s degree, professional degree, or equivalent from a foreign school that is considered
equivalent to the master’s degree or professional degree in Japan;iii. Hold a master’s degree, professional degree, or equivalent obtained in Japan through a distantlearning program offered by a foreign school;
iv. Hold a master’s degree, professional degree, or equivalent obtained after completion of aJapan-based foreign graduate program that is accredited by the national educational system in its
native country and accredited and designated separately by the Japanese Ministry of Education,
Culture, Sports, Science and Technology (MEXT);v. Hold a master’s degree or equivalent obtained after completion of a program at the United Nations
University, which was established with the approval of the General Assembly of the United
Nations on December 11, 1972, and specified in Article 1 Paragraph 2 of the Act on Special
Measures Incidental to Enforcement of the Agreement Between the United Nations and Japan
Regarding the Headquarters of the United Nations University (Act No. 72, 1976).
vi. Completed an education course at foreign school, educational institutions that have been
designated as qualifying for admission(4) or the United Nations University, and passed theexamination or review that are equivalent to the ones in Article 16-2 of Standards for
Establishment of University, and be accredited by the UGS-DDMIS as having academic ability
equivalent to a master’s degree.
vii. Be accredited by MEXT (MEXT Public Notice No. 118, 1989, finally amended on March 14,2012), i.e., (a) have worked at a university, research institute, or other relevant institution as a
researcher for at least two years after completion of a bachelor’s degree, a 16-year educational
program in a foreign country, or a Japan-based, 16-year distant learning educational program of aforeign country that is accredited by the national educational system in its native country; and (b)be accredited by the UGS-DDMIS as having academic ability equivalent to a master’s degree;viii. Be 24 years of age or older on or before the Above date, and be accredited by the UGS-DDMIS
through an individual qualification review has having academic ability equivalent to a master’s
degree or a professional degree, i.e., have graduated a two-year college, college of technology,
specialized training college, other Japanese school in the “miscellaneous” category, Japan-based
foreign university, international school, or ethnic school and be accredited by the UGS-DDMIS
through an individual qualification review as having academic ability equivalent to a master’s
degree;4Note: Applicants who fall under category vii) or viii) should carefully read the next section, “5.
Approval of Application Eligibility.”

5.

Approval of Application Eligibility(1) Before applying for admission, applicants who fall under category vii) or viii) in “Application
Eligibility” must apply for the eligibility assessment by submitting the following documents andbe approved as a person in “Category VII” or “Category VIII”
1)

Application for Eligibility Certification to UGS-DDMIS Program (including curriculum vitae)(Form 9);2)

University Certificate of Graduation (Expected Graduation) or Certificate of Diploma of Your
Final Academic Background ;3)

Statement of Research Achievement (Form 10);

4)

Copy of Published Academic Articles; (which were published in national level academic
meeting or journal)

5)

Certificate of English Language Proficiency, TOEIC Score, TOEFL Score and so on.

(2) Applicants who fall under category vii) in “Application Eligibility” are required to submit thefollowing documents additionally;
1) Certificate of Research Activities Issued by All Institutions, Companies, or Other Organizations
where the Applicant has Worked. This includes:
Research scholar certificate indicating the period of research activity, if the applicant
has worked as a university research scholar; and/or
Certificate of employment showing the period of employment and the applicant’s
department/division, if the applicant is currently working.
(3) Applicants who fall under category viii) in “Application Eligibility are required to submit thefollowing documents additionally;
1) Transcript from University or the Latest Academic Background.
2) Letter of Nomination from your Prospective Supervisor.
(4)Deadline and Notification of Assessment Decision
Application Period

Date of Review

Notification of Decision

Jul. 22th (Mon) to 24th (Wed), Sep. 5th (Thu), 2024

The

2024

notify the applicant of the(Applications must be received byresult on Sep. 19th (Thu),

5:00 pm on the deadline date.)

2024
5

UGS-DDMIS

will

Note:*If applications are sent via post, they must be sent by kan-i kakitome (simplified registered mail).
“Application for Program Eligibility Enclosed” should be noted on the left side of the envelope in
red ink.
*It is necessary to have the score of English Language Proficiency test, like TOEFL or TOEIC, andso on.
*We will conduct an interview (including an oral examination) for our eligibility assessment.
*Time and place of interview will be informed by RENGO SOUYAKU after receipt of application
form.
(5) Address and Contact Information
Office, United Graduate School of Drug Discovery and Medical Information Sciences
Gifu University
1-1 Yanagido, Gifu-shi, Gifu Prefecture 501-1194
Phone: +81-58-230-7602
E-mail: renso@t.gifu-u.ac.jp(6) About the applicants who fall under category vii) in “Application Eligibility”, we will show someexamples as below.
1) Faculty or research associate (full-time worker) who works at national or public or private
research institution, and has the research history at least 2 years.
2) Clinical laboratory technician, clinical radiologist, pharmacist and other medical care personnel(full-time worker) who works at university hospital or hospital which has a laboratory, and has
the research history at least 2 years.
3) Clinical laboratory technician, clinical radiologist, pharmacist and other medical care personnel(full-time worker) who works at medical institutions other than 2), and has the research history
as a university research student at least 2 years.
4) A person who works at a company and devote oneself to research in its R&S Dept., and has theresearch history at least 2 years.
5) A person who works at a company and has the career as a university research student at least 2
years.
6) Doctor, Dental Doctor, Animal Doctor (full-time worker), pharmacist(full-time worker) who has
the research history at least 2 years or has the career as a university research student at least 2
years.
When you are not clear if you would fall under the mentioned category or if you are graduate
with a degree in 6-year-program (including a future graduate) and do not fall under category (7 )of Application Eligibility, please contact to the (5) Address.
66.

Prior Consultation for Disabled Applicants
The Gifu University encourages all disabled applicants who may require additional support

during their entry examination to contact us prior to application as soon as you can.
The deadline and procedures for prior consultation are as follows:(1) Deadline for prior consultation
5:00 pm on Sep. 6th (Fri), 2024
(2) How to consult with the UGS-DDMIS:
Submit an Application Form for Disabled Applicants for Special Arrangements Before
Admission to the UGS-DDMIS along with a medical certificate or a copy of the applicant’s
physical disability certificate.
The applicant or an immediate family member may be asked to participate in an interview.
(3) How to request an application form:
To request for an Application Form for Disabled Applicants for Special Arrangements
Before Admission by mail, send a self-addressed return envelope (N4 size, 20.5 cm long ×
9.0 cm wide) with a standard-size envelop (14 to 23.5 cm long × 9 to 12 cm wide). Note
“Request for Application Form for Disabled Applicants for Special Arrangements Before
Admission” on the front of the envelope in red ink and send to:
Office, United Graduate School of Drug Discovery and Medical Information Sciences
Gifu University
1-1 Yanagido, Gifu-shi, Gifu Prefecture 501-1194
Phone: +81-58-230-7602(4) Applicants who become disabled after the deadline:
In the event of a disability occurring after the application deadline, for example due to an
unforeseen accident, applicants are encouraged to consult with the UGS-DDMIS at any
time.
7.

Application Procedure(1) How to apply
Applicants are required to complete the application registration on the "Application Site" andpayment of the application fee. Please refer to the attached "Web Application Flow".

(2) Required Documents1)
For all applicants:
7

Type of document(i)

Address

Notes

sheet

for

submitting

your After paying the application fee, you can print

application

it out in A4 size, single-sided in color from the“Application Site”. And attach the sheet to acommercially available Kaku2 envelope(24cm×33.2cm).

(ⅱ)

Application Form

After paying the application fee, you can print
it out in A4 size, single-sided in color from the“Application Site”.

(iii) Curriculum vitae (Form 1 or 2)

・Japanese applicants must use Form 1.
・International applicants must use Form 2.

(iv) Research proposal (Form 3)(v)

Declarationofapplicablespecific Carefully read “12. About the clarification of

categories (Form 8 or 9)

the scope of control for “deemed exports”
under the Foreign Exchange and Foreign
Trade Act (“FEFTA”)”.
・Japanese applicants must use Form 8.
・International applicants must use Form 9.

For selected applicants:
Type of document

Who must submit:(i)

Certificate ofApplicants who have completed an M.S. program (or theCompletion

first half of a program leading to a Ph.D. degree)

Certificate of Prospective

Applicants who have not completed but will complete anCompletion

M.S. program (or the first half of a program leading to a(ii)

Ph.D. degree) by the time of admission(iii)

Letter of Eligibility

Applicants who are approved in Category vii) and viii).

Approval(iv)

Academic Transcript

Applicants who have completed or will complete an M.S.
program or who are approved as Category vii.
Applicants who are approved as Category viii do not have toresubmit the transcript.

(v)

Summary of master’s

Applicants who have completed or will complete an M.S.

thesis (Form 4)

program (or the first half of a program leading to a Ph.D.
degree) by the time of admission(vi)Application fee of 30,000

Applicants who will complete an M.S. program at Gifu

yen

Pharmaceutical University or Gifu University in March or
September 2025, and international applicants who are8

funded by the Japanese government2) do not have to pay theapplication fee. Other applicants must:(For those who are eligible for the examination fee waiver)
1) Please send an e-mail to the UGS-DDMIS, stating thatapplicants are eligible for the exemption from theexamination fee.
E-mail: renso@t.gifu-u.ac.jp
2) After confirmation by the UGS-DDMIS, a password will
be sent to applicants.
3) Check the box on the” Application Site”.
4) Enter the password sent to applicants in step 2).
(Examination fee exemption for the applicants affected bydisasters)
Victims of the disasters are exempted from the application
fee. Applicants must submit the required documents by therequired date in advance. For more information, refer to theGifu University website(https://www.gifu-u.ac.jp).
(vii)

Permission for application

Applicants currently employed must submit a statement of(Form 5)

permission for application prepared and signed by thedepartmental director or employer(viii) Statement of Research
Achievement (From 7)

Applicants currently employed must submit.
Applicants who are approved as Category vii and viii do nothave to resubmit.

(ix)

Copy of alien registration

International applicants who are staying in Japan at the timecertificate or short-stayof application3)

visa
(x)

Official Score Certificate

Applicants who have taken TOEFL or TOEIC or otherof English Proficiency

examinations from an external organization submit the

Test.

score. Applicants who are approved as Category vii) andviii) do not have to resubmit it.

Notes:
1)

Before application, consult your prospective mentor about application procedures.

2)“International applicants who are funded by the Japanese government” refers to applicants who

have already been accepted for funding for the course of study. This category does not include theapplicants wishing to apply for national funding after admission.
9

3)

Refers to international applicants who do not have Japanese citizenship and are staying in Japan

under some form of status of residence.
(3) The Period of Register the Application forms and Document AcceptanceRegister the Application forms Period

Remarks

Sep. 19th (Thu) to Oct. 2nd (Wed), Please2024(1:00 p.m.)completetheapplication

registration on the "Application Site" andpayment of the application fee by theperiod shown on the left.

Document Acceptance Period

Remarks

Sep. 27th (Fri) to Oct. 2nd (Wed), 2024

Mailed applications must be received on

Hand-delivered

applications

must

be or before Oct. 2nd (Wed), 2024.

received between 9:00 am and 5:00 pm
during this period.
Notes:*Once submitted, any change in the application forms is not permitted. Submitted applicationmaterials are not returned.
*Whether you bring or send application materials by mail, please attach “Address sheet for
submitting your application” to the envelope.
*If application materials are sent via post, they must be sent by kan’i kakitome (simplified registeredmail).
(4) Address and Contact Information:
Office, United Graduate School of Drug Discovery and Medical Information Sciences
Gifu University
1-1 Yanagido, Gifu-shi, Gifu Prefecture 501-1194
Phone: +81-58-230-7602
E-mail: renso@t.gifu-u.ac.jp

8.

Examinations
Admission decision is based on the result of interview and documentary examination, Research(hope) plan, Academic Transcript, Summary of master’s thesis. In the case of the applicants
currently employed, Permission for application and Statement of Research Achievement are also
10part of documentary examination.
Perfect score is 100 points. Applicants who gets less than 60 points are disqualified.

9.

Date and Venue for Examination
Date: October 31st (Thu), 2024
Examination

13:00～

Interview

Venue

The interview will be about 30 minutes long and 8th floor, Gifu
include:Pharmaceutical University(located on the campus ofApplicant’s presentation (20 min)Give a paper or electronic presentation on ➀ the School of Medicine,
your past research, result ②your research plan in Gifu University)
our graduate school. Use PowerPoint (Windows
only)

softwaretopreparetheelectronicpresentation and provide the file on a USB driveor bring your own computer.
Oral examination (approx. 10 min)Faculty members will ask questions about
your presentation, research proposals, summary ofmaster’s thesis, and other issues related to yourresearch area.
Notes: The Entrance Examination Ticket (print it out in A4 size, single-sided in color from the“Application Site”.) must be presented at the examination site.
In the case of interview through a video conference system, we will conduct an interview between
Sep. 28th and 31st, 2024.

10. Announcement of Admission Decisions
November 19th (Tue), 2024

10:00 AM

Admission results will be posted on the bulletin board on the 8th floor of Gifu Pharmaceutical
University, and it will be put on our website (https://www.gifu-u.ac.jp/), too. Successful applicants
will be able to download an acceptance letter from “Application Site”.
*Admission result on our website will be shown for one week from the Nov. 19th, 2024. This isjust one of our information providing service. Please make sure to confirm an acceptance letter11

separately from website.

11. Registration
To confirm your acceptance of an offer of admission, the following steps must be taken:(1) The admission procedure will be conducted via the “Application Site". Details will be announced
at a later date.
(2) Admission fee and tuitionsa)Admission fee:

282,000 yen TBCb)Tuition:267,900 yen/semester (535,800 yen/year) TBC

Notes:
If the tuition is changed during the course of study, the new tuition will be applied from theeffective date.
The admission fee and tuition will be waived for international students who are funded by
the Japanese government.

12. About the clarification of the scope of control for “deemed exports” under the Foreign
Exchange and Foreign Trade Act (“FEFTA”)
In November 2021, in accordance with the clarification of the scope of control for “deemed
exports” under the Foreign Exchange and Foreign Trade Act (“FEFTA”), some provision ofsensitive technology to students by universities and research institutions has become subject tocontrol under the FEFTA. Consistently with this change, when applying to study at the
University, students will be required to submit a “Declaration of applicable specific categories”
based on the “Flowchart for determining applicable specific categories.” some students will also
be required to submit a “Letter of confirmation” at the time of their recruitment or admission.

13. Notes to All Applicants(1)Handling of personal information
Your name, birthdate, address, phone number, and any other personal information provided on
application forms will be entered in our admission information processing system. Gifu University
has a responsibility to manage and store registered information and submitted application forms.
After application and admission procedures, no provided information will be disclosed to any third
party or person other than our admissions staff, which requires access to the information for12administrative purposes. Provided information will be used only when:i) the data is necessary in order to process the admission of accepted applicants;ii) issuing student ID cards, completing course registrations, managing academic records, andperforming other administrative procedures as are necessary during the student’s course of
study;
iii) conducting surveys or statistical analysis related to admission (in this case, only certain
personnel are responsible for using the data for statistical and analytical purposes, and data
will be disclosed without personal identification);iv) the prior consent of the individual in question is obtained; orv) such use is required by law.
(2)Application fee refund policy①Except following situation, the Entrance Examination Fee will not be refunded in principle.
a. the application was not accepted;
b. the fee was accidentally paid twice.
c. the fee was paid, but the application was not submitted.
②How to request a refund
Submit the receipt or statement of use, etc. and a Refund Request that includes the below listed
information a) to f) to the office of the United Graduate School of Drug Discovery and Medical
Information Sciences, (Gifu University, 1-1 Yanagido, Gifu-shi, Gifu Prefecture 501-1194)(“Application Fee Refund Request Enclosed” should be written in red on the envelope) Refund
requests should be sent from Oct. 3th (Thu) to Nov. 1st (Fri), 2024.
a. The reason for refund
b. Name (with furigana) and seal (or signature) of the applicant
c. Current address
d. Contact phone number
e. Program course to which application was madef. Bank account information: Bank name, branch, type of account, account number, and accountholder’s name with furigana(3)About disclosure of admission decisions
We do not disclose the score of interview examination.

13

II. Overview of the United Graduate School of Drug Discovery and Medical Information
Sciences (UGS-DDMIS)
1. Educational and Research Mission
The fundamental goal of UGS-DDMIS is to foster advanced professionals of next generation
who are capable of playing leadership roles in the most advanced fields in medicine, medical science,and life science through their highly specialized skills, foresight, and flexible thinking. To this end,
UGS-DDMIS is committed to promoting the quality of its graduate programs throughinterdisciplinary education and research activities in the biological and life sciences, with a specificfocus on drug discovery and medical information.
2. Doctorate Programs and Research Areas(1) Medicinal Sciences Program
1) Program Overview
Today, rapidly emerging new infectious diseases, lifestyle-related diseases, and preventive
medicine are areas of the highest priority on the national agenda. To address these issues, we needsystematic education and research in the area of drug discovery, which brings together a prodigious
amount of structural and functional information related to genes and proteins through advanced
technologies in genome science and structural biology. In our drive to endow students with a solid
foundation in human genome informatics and structural biology in addition to conventional chemical
technologies, we offer education and research opportunities ranging from the fundamentals of
biology- and genetics-based drug discovery processes to the diagnosis of modern diseases in amanner that is derived from functional analysis at the cellular and individual levels.
The ultimate goal of the program is to train technical experts and researchers in the field of drug
discovery so that they can contribute to the pharmaceutical and biotechnology industries as well as
the academic and research sectors.
2) Research Areasi) Biological Molecular Sciences
Establishment of a new drug discovery research platform built upon human genome
information is an urgent need as scientists pursue pharmacological approaches to deal with
rapidly emerging diseases and lifestyle diseases. To this end, integration of leading-edge
information and technologies in genome science, structural biology, and other life science areas
is essential for education and research in drug discovery science. This area of the program
focuses on understanding biological phenomena arising from the interactions between
14biomacromolecules and organic small molecule compounds by combining chemical andbiological methods with chemical genetics approaches while providing educational and research
opportunities that form a basis for processes conceived to discover new functional molecules.
ii) System Biological Technologies
To address rapidly emerging new diseases, acceleration of pharmaceutical research anddevelopment of early diagnostic tools are high priorities. In order to accomplish these things, itis necessary to reduce dependency on in-life experiments by developing high-throughput
biofunctional assay technologies, genetic diagnostics, and disease biomarkers based on in vitro
systems using enzymological and cellular approaches. This area of the program emphasizes
education and research in prevention, therapy, and diagnosis of modern diseases by addressing
the interactions and regulatory mechanisms at het molecular, cellular and individual levels in
the context of the concept of life as a network system.
(2) Medical Information Sciences Program
1) Program Overview
There is a pressing need to develop human resources to address issues such as adverse drug
reactions and drug-related accidents as well as to realize individualized medicine, a mode of care thatis in high demand. We are providing education and research opportunities in analysis and processingof a vast amount of individually detailed patient information, i.e., technologies that are essential inestablishing an interdisciplinary, cross-sectoral and innovative research area to meet the demandingneeds of individualized and preventive medicine. Also part of our educational and research focus are
the analysis and evaluation of the biological responses to pharmacological agents andpharmacological regulation of diseases.
By providing such educational and research opportunities, we aim to train advanced healthcare
professionals who are highly skilled in the research methods that will be required to realize tailored
medicine, health science, and leading-edge medical technology as well as to train technical andresearch experts in quality assurance procedures in the food and cosmetics industries as well as theacademic and governmental sectors.
2) Research Areasi) Biomedical Informatics
In an effort to realize individualized and preventive medicine based upon aninterdisciplinary, cross-sector, and innovative research platform, this area of the programprovides education and research opportunities in the fundamental technologies andmethodologies required for customized medicine through the accumulation, analysis, and15

assessment of the latest medical information on lifestyle-related diseases and emerging andreemerging infectious diseases. Development of preventive and therapeutic interventional
strategies through analysis of desired and unwanted effects of pharmacological agents from thestandpoint of genetic polymorphism is another area of educational and research focus in thisprogram.
ii) Biofunctional Control
This area of the program aims to understand the body’s physiological response to, anddisease-control mechanisms of, new drug candidates for such conditions as immune, allergic,
and infectious diseases, and to provide a foundation for education and research that emphasizes
approaches ranging from structural biology to drug discovery and from harmacodynamics andmetabolic pathway analysis to the development of biofunctional control.
3. Degrees Offered
The following degrees are offered by the UGS-DDMIS:
Program

Degree Offered

Medicinal Sciences

Doctor of Philosophy in Doctor of Philosophy in
Engineering

MedicalPharmaceutical Science

Information Doctor of Philosophy in Doctor of Philosophy in

Sciences

Pharmaceutical Science

Medical Science

4.Degree Requirements, Course Registration and Register Extending System(1) Degree Requirements
To complete the program, a minimum of 13 course credits, satisfactory completion and defense ofa dissertation, and satisfactory completion of an academic competency review are required.
Courses:

Basic Courses

A minimum of four credits of core courses
and a minimum of two credits of elective courses
are required.

Major Courses

A minimum of two credits of core courses
within the student’s major area, a minimum of
two credits of dissertation research, and aminimum of two credits of elective courses are
required.
16

Tofacilitate

interdisciplinary

education,

students are encouraged to select elective courses
from areas other than their majors.
Field Practice:

The objective of field practice is to experiencestate-of-the-art

researchmethodologies

andtechnologies through direct interactions withsenior researchers in an outside setting such as a
research organization or corporate lab that is
involved in the field of drug discovery. The
course is offered as a Required Basic Subjects(one credit).
(2) Course Registration①Students must consult with the instructor of the course prior to registration.
②Students must complete basic course requirements by the end of their second year. All
students must choose a dissertation research subject in their first year and undertake dissertation
research (drafting a research proposal, finding reference articles, conducting research, andanalyzing and reviewing the results) under the supervision of their mentors.
③We have some classes in the weekend because there are some students who have a job.
④If appropriate and approved, students may take courses at other graduate schools or undertake
research at other graduate schools, hospitals, and other advanced facilities.
⑤UGS-DDMIS gives a English Course which aims to raise the level up of students English
skills. This course is given freely, but you can not get credit because it is not our regular course.
And then, we recommend the students to take the TOEIC test in order to check yourachievement and improve your skills moreover. We subsidize the expense of examination fee.
(3) Register Extending System①This system is for the employed or otherwise eligible students. They may have their study
period extended for a maximum of six years with the permission of the president of University,
if they plan to stay in the program for longer than the required period of time (three years)17

②Even if approved for extension, students only need to pay three academic years’ worth oftuition. The cost will be divided by the number of years for which the student has been approved
to stay in the program, with the resulting amount to be paid annually.

5. Courses & Credits
Please refer to our website. < https://www.souyaku.gifu-u.ac.jp/english/overview/006kamoku/>

18

6. Faculty List
Please refer to our website. < https://www.souyaku.gifu-u.ac.jp/english/outline/organization_member/>Name

Academic

BelongingResearch Area

Medicinal

Bio-functional Supramolecular Materials

Position
Masato Ikeda

Professor

Sciences
Hiroshi Ueda

Yukihiro Esaka

Dean

Medicinal

Professor

Sciences

Professor

Medicinal

Cell Biology

Precision Separation and Analytical Chemistry

Sciences
Kentaro Ohashi

Professor

Medicinal

Neuroscience, Cell Biology

Sciences
Hiroshi Takemori

Professor

Medicinal

Pathology control studies

Sciences
Takashi Yokogawa

Professor

Medicinal

Molecular Biology, Biochemistry,

Sciences
Satoshi Endo
Hiroko Koyama
Ryo Honda
Zenichiro Kato

Associate

Medicinal

Biochemistry, Enzymology, Structural biology

Professor

Sciences

Associate

Medicinal

Professor

Sciences

Associate

Medicinal

Structural Biology, Protein Science,

Professor

Sciences

Molecular-targeting therapeutics

Professor

Medical

Structural Medicine

Organic Chemistry

Information
Sciences
Kaori Tanaka

Professor

MedicalAnaerobic Bacteriology and Clinical Microbiology

Information
Sciences
Hiroyuki Tanaka

Associate

MedicalProfessor

Information

Pharmacology, Immunopharmacology and Allergology

SciencesTomoyoshi Terada

Professor

MedicalPhisiology, Allergology

Information
Sciences
Eiichi Hinoi

Professor

MedicalPharmacology, Medicinal Chemistry

Information
Sciences
19Daisuke Fukuoka

Professor

Medical

Medical Image Processing

Information
Sciences
Mayumi

Professor

Yamamoto

MedicalEndocrinology and Metabolism, Health Science, and Medical

Information

Management

Sciences
Takashi

Associate

MedicalIchinomiya

Professor

Information

Medical Information, Network Theory, Bioinformatics

Sciences
Chiemi Saigo

Associate

MedicalProfessor

Information

Human Pathology

Sciences
Shigeo Takashima

Associate

MedicalProfessor

Information

Developmental Genetics

Sciences
Ryo Horita

Associate

MedicalProfessor

Information

Health Science, Psychology

Sciences

Name

Academic Position

Belonging

Takashi Kato

Visiting Professor

NCGG

Kimura Yasuyuki

Visiting Professor

NCGG

Michinori Funato

Visiting Professor

Nagara Medical Center20